Copyright
©The Author(s) 2020.
World J Hepatol. Dec 27, 2020; 12(12): 1349-1357
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1349
Published online Dec 27, 2020. doi: 10.4254/wjh.v12.i12.1349
Figure 1 Preoperative computed tomography findings.
Before lenvatinib administration, tumor stain was observed in the arterial phase and washout was observed in the portal phase. After lenvatinib administration, the tumor stain disappeared in the arterial phase, and the tumor size was found to have decreased slightly in the portal phase. A and B: Images of the arterial phase (A) and portal phase (B) before administration of lenvatinib; C and D: Images of the arterial phase (C) and portal phase (D) after lenvatinib administration.
- Citation: Yokoo H, Takahashi H, Hagiwara M, Iwata H, Imai K, Saito Y, Matsuno N, Furukawa H. Successful hepatic resection for recurrent hepatocellular carcinoma after lenvatinib treatment: A case report. World J Hepatol 2020; 12(12): 1349-1357
- URL: https://www.wjgnet.com/1948-5182/full/v12/i12/1349.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i12.1349